CSPP1 Activators represent a diverse group of chemical compounds that exert their influence on the functional activity of CSPP1 through various molecular mechanisms. These compounds play a crucial role in enhancing CSPP1-mediated cellular processes, primarily in the context of cell adhesion and signaling. Forskolin, for instance, indirectly enhances CSPP1 by elevating intracellular cAMP levels, leading to the activation of PKA, which, in turn, phosphorylates substrates involved in CSPP1-related cellular functions. Genistein, on the other hand, acts as an indirect activator by inhibiting tyrosine kinases, reducing competition from tyrosine kinase signaling pathways, and allowing CSPP1 pathways to be more active. Compounds like Sphingosine-1-phosphate and Thapsigargin impact CSPP1 through lipid and calcium signaling modulation, respectively, potentiating cellular processes where CSPP1 is crucial, particularly those related to cell adhesion.
Furthermore, chemicals like PMA activate CSPP1 through PKC, promoting adhesion-related pathways and enhancing CSPP1-mediated functions. Epigallocatechin gallate (EGCG), LY294002, and Wortmannin contribute to CSPP1 activation by reducing competition from kinase signaling pathways, favoring CSPP1-related processes. SB203580 and U0126 exert their influence by inhibiting specific kinases within the MAPK pathway, shifting the signaling equilibrium to pathways associated with CSPP1, ultimately enhancing its functional activity. A23187 enhances CSPP1 by increasing intracellular calcium levels, thereby activating calcium-dependent signaling pathways crucial for cell adhesion processes. Lastly, Staurosporine, despite being a broad-spectrum protein kinase inhibitor, may selectively activate CSPP1 pathways by relieving the inhibition exerted by specific kinases on CSPP1-related processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances CSPP1's functional activity through the elevation of intracellular cAMP levels, leading to the activation of PKA. This activation, in turn, phosphorylates substrates involved in CSPP1-related cellular processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein indirectly augments CSPP1 pathways by inhibiting tyrosine kinases, reducing competition from tyrosine kinase signaling and allowing CSPP1-related pathways to be more active. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate influences CSPP1 activity through the modulation of lipid signaling, potentiating cellular processes in which CSPP1 is involved, particularly those related to cell adhesion. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin indirectly activates CSPP1 by influencing calcium signaling, which is crucial for CSPP1-related cellular processes, ultimately enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates CSPP1 via PKC, promoting adhesion-related pathways and enhancing CSPP1-mediated functions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a kinase inhibitor, contributes to the activation of CSPP1 by reducing competition from kinase signaling pathways, allowing CSPP1 pathways to be more active. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, enhances CSPP1 activity by reducing the influence of PI3K signaling, favoring CSPP1-related pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, indirectly activates CSPP1 by reducing PI3K-related competition and promoting CSPP1-mediated cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 influences CSPP1 by inhibiting p38 MAPK, shifting the signaling equilibrium to favor pathways associated with CSPP1, ultimately enhancing its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 enhances CSPP1's functional activity by increasing intracellular calcium levels, activating calcium-dependent signaling pathways crucial for CSPP1-related processes. | ||||||